About Us
Our Company
Our Leadership
Precision Science
Power of GPCRs
Unique & Proprietary Approach
Our Programs
Partnerships
Our Partnerships
Our Partners
News & Media
Press releases
News
Media Highlights
Downloads
Careers
Search on our website
Type Enter to start searching.
Pipeline
Scroll to explore
Latest
Scroll back top
1 July 2025
Drug Target Review – How GPCR-targeting therapies are advancing the fight against inflammatory...
Discover more
24 June 2025
Drug Discovery World – Expert commentary from ASCO 2025
Discover more
10 June 2025
Labiotech – ASCO 2025: key highlights in cancer therapeutics
Discover more
3 June 2025
Pharmaphorum – AACR 2025: New modalities and remaining challenges
Discover more
20 May 2025
Newsweek Investment Reports – Interview with Sean A. MacDonald, CEO of Domain Therapeutics
Discover more
7 May 2025
Discover Pharma – Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025
Discover more
30 April 2025
Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025
Discover more
11 April 2025
Investors Hangout – Domain Therapeutics Unveils Innovative GPCR Research Findings
Discover more
1 April 2025
Domain Therapeutics to Present Data on its GPCR Lead Programs at AACR Annual Meeting 2025
Discover more
27 March 2025
Investors Hangout – Revolutionizing inflammatory disease treatment with DT-9046
Discover more